The JAK-STAT pathway is a potential target for treatment of pediatric kidney tumors and research efforts have been aimed at understanding mechanisms of resistance to immunotherapy and how anti-tumor immune response can be therapeutically enhanced. Here, SOAT1 is linked to neoplasm.